BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/2/2022 12:11:47 PM | Browse: 353 | Download: 747
Publication Name World Journal of Gastroenterology
Manuscript ID 73996
Country/Territory Hungary
Received
2021-12-13 07:31
Peer-Review Started
2021-12-13 07:33
To Make the First Decision
Return for Revision
2022-01-23 06:34
Revised
2022-02-01 10:34
Second Decision
2022-04-20 02:21
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-04-25 19:54
Articles in Press
2022-04-25 19:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
2022-04-13 04:10
Typeset the Manuscript
2022-05-20 08:19
Publish the Manuscript Online
2022-06-02 12:11
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Serological biomarkers for management of primary sclerosing cholangitis
Manuscript Source Invited Manuscript
All Author List David Tornai, Peter Laszlo Ven, Peter Laszlo Lakatos and Maria Papp
ORCID
Author(s) ORCID Number
David Tornai http://orcid.org/0000-0002-1335-5498
Peter Laszlo Ven http://orcid.org/0000-0001-8990-7757
Peter Laszlo Lakatos http://orcid.org/0000-0002-3948-6488
Maria Papp http://orcid.org/0000-0003-3662-4010
Funding Agency and Grant Number
Funding Agency Grant Number
Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund 138041
EFOP projects co-financed by the European Union and the European Social Fund EFOP-3.6.1-16-2016-00022
Corresponding Author Maria Papp, DSc, FEBG, MD, PhD, Full Professor, Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 98 Nagyerdei krt, Debrecen H-4032, Hajdu-Bihar, Hungary. papp.maria@med.unideb.hu
Key Words Primary sclerosing cholangitis; Hepatobiliary; Serological biomarker; Immunoglobulin; Inflammatory; Tissue remodeling
Core Tip Recent advances in biomarker research may help clinicians identify relevant subgroups of primary sclerosing cholangitis (PSC) and assist everyday clinical work-up. However, a diagnostic biomarker is still an unmet need. On the other hand, several biomarkers have been reported to predict outcome in PSC; however, most of them have not been validated by subsequent studies. The IgA type anti-glycoprotein 2 antibody is the first one to be supported by a satisfactory number of clinical studies and could be incorporated into clinical practice. These discoveries also reveal different aspects of PSC providing with potential therapeutic targets.
Publish Date 2022-06-02 12:11
Citation Tornai D, Ven PL, Lakatos PL, Papp M. Serological biomarkers for management of primary sclerosing cholangitis. World J Gastroenterol 2022; 28(21): 2291-2301
URL https://www.wjgnet.com/1007-9327/full/v28/i21/2291.htm
DOI https://dx.doi.org/10.3748/wjg.v28.i21.2291
Full Article (PDF) WJG-28-2291.pdf
Full Article (Word) WJG-28-2291.docx
Manuscript File 73996_Auto_Edited_LM.docx
Answering Reviewers 73996-Answering reviewers.pdf
Audio Core Tip 73996-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 73996-Conflict-of-interest statement.pdf
Copyright License Agreement 73996-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 73996-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 73996-Language certificate.pdf
Supplementary Material 73996-Supplementary material.pdf
Peer-review Report 73996-Peer-review(s).pdf
Scientific Misconduct Check 73996-Bing-Chen YL-2.png
Scientific Editor Work List 73996-Scientific editor work list.pdf